Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

45.62 -0.36 (-0.78%)
Streaming Delayed Price Updated: 3:28 PM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 186,359
Open 44.91
Bid (Size) 45.56 (300)
Ask (Size) 45.68 (100)
Prev. Close 45.98
Today's Range 43.59 - 46.48
52wk Range 23.23 - 48.18
Shares Outstanding 32,250,236
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Collegium Pharmaceutical Inc (NASDAQ:COLL) Shows High Growth Momentum with Strong Technicals ↗
Discover how Collegium Pharmaceutical (COLL) combines a strong technical uptrend with powerful earnings growth, marking it as a high-potential stock. 
Via Chartmill
News headline image
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q3 Earnings Call
Collegium Pharmaceutical’s third quarter was marked by robust demand for its ADHD medication Jornay PM and continued resilience in its pain management portfolio. Management pointed to a successful... 
Via StockStory
Topics Earnings

Performance

YTD
+59.3%
+59.3%
1 Month
+34.4%
+34.4%
3 Month
+19.5%
+19.5%
6 Month
+52.9%
+52.9%
1 Year
+56.1%
+56.1%

More News

Read More
News headline image
1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off
Via StockStory
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
News headline image
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
2 Momentum Stocks with Exciting Potential and 1 We Find Risky
Via StockStory
Topics Credit Cards
News headline image
COLL Q3 Deep Dive: Jornay PM Momentum and Pain Portfolio Drive Upgraded Outlook
Via StockStory
News headline image
Why Are Collegium Pharmaceutical (COLL) Shares Soaring Today
Via StockStory
Topics Economy Government World Trade
News headline image
Collegium Pharmaceutical Inc (NASDAQ:COLL) Beats Q3 2025 Estimates and Raises Full-Year Guidance ↗
Via Chartmill
News headline image
Collegium Pharmaceutical (NASDAQ:COLL) Delivers Impressive Q3, Stock Jumps 12.1%
Via StockStory
News headline image
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Earnings To Watch: Collegium Pharmaceutical (COLL) Reports Q3 Results Tomorrow
Via StockStory
News headline image
3 Stocks Under $50 That Fall Short
Via StockStory
Topics Artificial Intelligence
News headline image
Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Pharmaceutical (COLL): Buy, Sell, or Hold Post Q2 Earnings?
Via StockStory
Topics Stocks Supply Chain
News headline image
Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
UnitedHealth, Brookdale, Collegium Pharmaceutical, QuidelOrtho, and Biogen Shares Are Falling, What You Need To Know
Via StockStory
Topics Economy Government World Trade
News headline image
1 Russell 2000 Stock to Research Further and 2 We Avoid
Via StockStory
News headline image
Branded Pharmaceuticals Stocks Q2 Highlights: Collegium Pharmaceutical (NASDAQ:COLL)
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
1 Safe-and-Steady Stock to Keep an Eye On and 2 Facing Headwinds
Via StockStory
News headline image
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
1 Stock Under $50 Worth Investigating and 2 We Ignore
Via StockStory

Frequently Asked Questions

Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?
Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.
What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?
Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?
The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market
What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?
The current price of Collegium Pharmaceutical, Inc. - Common Stock is 45.62
When was Collegium Pharmaceutical, Inc. - Common Stock last traded?
The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 11/17/25 03:28 PM ET
What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?
The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 1.47B
How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?
Collegium Pharmaceutical, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.